Quest Diagnostics Incorporated
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $420.0M | $549.0M | $686.0M | $315.0M | $872.0M | $1.16B | $1.19B | $135.0M |
| Accounts Receivable | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B |
| Inventory | $189.0M | $188.0M | $190.0M | $192.0M | $208.0M | $223.0M | $123.0M | $99.0M |
| Total Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B |
| Property, Plant & Equipment | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.10B | $6.87B | $6.62B | $6.56B |
| Intangible Assets (Excl. Goodwill) | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B |
| Liabilities | ||||||||
| Accounts Payable | $307.0M | $287.0M | $378.0M | $324.0M | $357.0M | $446.0M | $263.0M | $222.0M |
| Total Current Liabilities | $2.28B | $2.17B | $1.82B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B |
| Long-Term Debt | $5.17B | $5.62B | $4.41B | $3.98B | $4.01B | $4.01B | $3.97B | $3.43B |
| Total Liabilities | $9.06B | $9.38B | $7.72B | $6.94B | $7.17B | $7.27B | $7.20B | $5.79B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $9.99B | $9.36B | $8.83B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B |
| Total Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B |